Suchergebnisse - covid-19

PubPharm (670.767)

11

COVID-19 pandemic. Stress test for health systems or the opportunity to revive Primary Care

enthalten in: Semergen | 2024

von Vázquez, J. | Serrano-Cumplido, A.

12

Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19

enthalten in: Vaccine | 2024

von Maltezou, H. | Kontogianni, S. | Michailidou, E. | +7

13

Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease

enthalten in: Vaccine | 2024

von Gong, J. | Barnboym, E. | O'Mara, M. | +5

14

Physical fitness levels and trends of kindergarteners in Hong Kong during the COVID-19 pandemic

enthalten in: Journal of exercise science and fitness | 2024

von Wong, M. | Ou, K. | Wong, W. | +2

15

Incidence and Mortality of COVID-19-Associated Invasive Fungal Infections Among Critically Ill Intubated Patients : A Multicenter Retrospective Cohort Analysis

enthalten in: Open forum infectious diseases | 2024

von Zuniga-Moya, J. | Papadopoulos, B. | Mansoor, A. | +3

16

Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults : A phase 3, randomized, active-controlled, multicenter trial

enthalten in: Vaccine | 2024

von Nurdin, A. | Movieta Nency, Y. | Maddeppungeng, M. | +24

17

Detection of SARS-CoV-2-specific mucosal antibodies in saliva following concomitant COVID-19 and influenza vaccination in the ComFluCOV trial

enthalten in: Vaccine | 2024

von Baum, H. | Thirard, R. | Halliday, A. | +13

18

A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases

enthalten in: Vaccine | 2024

von Schultze, A. | Martin, I. | Messina, D. | +18

19

Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021

enthalten in: Vaccine | 2024

von Archer, H. | McCoy, S. | Sears, D. | +4

20

Immunogenicity and safety of Sinovac-CoronaVac booster vaccinations in 12-17- year-olds with clinically significant reactions from Pfizer-BNT162b2 vaccination

enthalten in: Vaccine | 2024

von Chong, C. | Kam, K. | Zhang, J. | +8